As of May 3, 2021, a total of 8.6 thousand cartons of coronavirus disease (COVID-19) vaccination developed by Pfizer Inc. and BioNTech SE were planned to be supplied to medical professionals in Japan. The distribution of Pfizer-BioNTech COVID-19 vaccinations for approximately 4.8 million health professionals was to be completed with the last one thousand cartons of supplementary supply in the week of May 10 to 16, 2021.
The supply of COVID-19 vaccination in Japan has begun on February 17, 2021, mainly for health professionals. On April 12, 2021, the government started the vaccine administration for citizens aged 65 and older.
Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021
(in cartons)
*According to the source, 1,000 cartons should be enough to administer first and second doses of COVID-19 vaccinations to the remaining number of medical professionals and complete vaccinations for all health professionals.
A carton includes 195 vials, which equates to 975 doses (five doses per one vial) or 1,170 doses (six doses per one vial).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
MHLW (Japan). (May 3, 2021). Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan). "Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons)." Chart. May 3, 2021. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan). (2021). Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan). "Planned Supply Number of Coronavirus Disease (Covid-19) Vaccine for Medical Professionals Developed by Pfizer-biontech in Japan as of May 3, 2021 (in Cartons)." Statista, Statista Inc., 3 May 2021, https://www.statista.com/statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
MHLW (Japan), Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) Statista, https://www.statista.com/statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/ (last visited December 22, 2024)
Planned supply number of coronavirus disease (COVID-19) vaccine for medical professionals developed by Pfizer-BioNTech in Japan as of May 3, 2021 (in cartons) [Graph], MHLW (Japan), May 3, 2021. [Online]. Available: https://www.statista.com/statistics/1236499/japan-supply-number-pfizer-covid-19-vaccine-medical-professionals/
